|
|
|
|
||
AMAG Hits New Low as Makena No Better than Placebo in 1700 Patient Post-Approval Trial; Questions Raised about Study Group DifferencesAnyone see that risk factor coming? Ouch! Unclear what comes next. Good that we have so many irons in the fire. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
336 | Re: AMAG Hits New Low as Makena No Better than Placebo in 1700 Patient Post-Approval Trial->Updated on 3/18/2019 | simonig | 1 | 3/8/2019 5:50:19 PM |